Listed

Replimune Group, Inc.: Form 10-K for the period ended Mar 31, 2021

Filed with the SEC on May 20, 2021 and accepted by EDGAR at May 20, 2021, 08:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2020-04-01 to 2021-03-31$56.8mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2020-04-01 to 2021-03-31−$80.0mus-gaap:OperatingIncomeLoss
Income tax12 months2020-04-01 to 2021-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$21.5mus-gaap:NetIncomeLoss
Net income12 months2020-04-01 to 2021-03-31−$80.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.42us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-04-01 to 2021-03-31−$61.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-04-01 to 2021-03-31$2.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$182.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$483.7mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$543.1mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$14.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$44.4mus-gaap:Liabilities
Shareholders' equityAt period end2021-03-31$498.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-21-069611. Last ingested by Listed: Nov 11, 2026, 01:43 ET. Listed shows no prices and gives no investment advice.